Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$110M |
| 2 |
Willis Towers Watson
WTW
|
+$70.4M |
| 3 |
Gen Digital
GEN
|
+$63.3M |
| 4 |
Goldman Sachs
GS
|
+$53.6M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$51.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$110M |
| 2 |
Meta Platforms (Facebook)
META
|
+$72.2M |
| 3 |
Global Payments
GPN
|
+$43.3M |
| 4 |
Cardinal Health
CAH
|
+$41.2M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$40.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.08% |
| 2 | Technology | 14.83% |
| 3 | Healthcare | 8.61% |
| 4 | Consumer Discretionary | 7.67% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
CEMIG Preferred Shares
CIG
$5.58B
| $215K | ﹤0.01% |
143,988
-473,742
| -77% | -$666K |
|
|
MAXN
1727
DELISTED
Maxeon Solar Technologies
MAXN
| $215K | ﹤0.01% |
+122
| New | +$209K |
|
1728
Vericel Corp
VCEL
$2.17B
| $215K | ﹤0.01% |
4,400
-4,922
| -53% | -$255K |
|
1729
Viasat
VSAT
$9.96B
| $215K | ﹤0.01% |
+3,900
| New | +$199K |
|
1730
RLJ Lodging Trust
RLJ
$1.76B
| $214K | ﹤0.01% |
14,400
+3,700
| +35% | +$53.1K |
|
|
PENG
1731
Penguin Solutions Inc
PENG
$2.6B
| $214K | ﹤0.01% |
9,600
-3,000
| -24% | -$71.8K |
|
|
FRON
1732
DELISTED
Frontier Acquisition Corp. Class A Ordinary Shares
FRON
| $214K | ﹤0.01% |
22,059
+7,059
| +47% | +$68.6K |
|
1733
Lindsay Corp
LNN
$1.18B
| $213K | ﹤0.01% |
1,400
-500
| -26% | -$80.7K |
|
1734
Immunovant
IMVT
$8.95B
| $212K | ﹤0.01% |
24,400
-25,600
| -51% | -$231K |
|
1735
Qualys
QLYS
$6.17B
| $212K | ﹤0.01% |
1,900
-3,800
| -67% | -$416K |
|
1736
First Bancorp
FBNC
$2.7B
| $211K | ﹤0.01% |
4,900
| – | – |
|
1737
NovoCure
NVCR
$1.95B
| $211K | ﹤0.01% |
+1,812
| New | +$274K |
|
|
ARNC
1738
DELISTED
Arconic Corporation
ARNC
| $211K | ﹤0.01% |
+6,700
| New | +$229K |
|
|
NOGN
1739
DELISTED
Nogin, Inc. Common Stock
NOGN
| $210K | ﹤0.01% |
+1,065
| New | +$210K |
|
1740
Harmony Gold Mining
HMY
$14.3B
| $209K | ﹤0.01% |
+66,100
| New | +$243K |
|
1741
The Joint Corp
JYNT
$119M
| $209K | ﹤0.01% |
2,129
-2,071
| -49% | -$194K |
|
1742
Omeros
OMER
$1.4B
| $209K | ﹤0.01% |
15,182
-4,608
| -23% | -$69K |
|
|
ARGO
1743
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $209K | ﹤0.01% |
+4,005
| New | +$210K |
|
|
ZOM
1744
DELISTED
Zomedica Corp.
ZOM
| $209K | ﹤0.01% |
399,217
-199,035
| -33% | -$117K |
|
|
ALX
1745
Alexander's
ALX
$1.38B
| $208K | ﹤0.01% |
+800
| New | +$214K |
|
1746
ProShares Ultra Bloomberg Natural Gas
BOIL
$407M
| $208K | ﹤0.01% |
+13
| New | +$128K |
|
1747
Eagle Bancorp
EGBN
$857M
| $208K | ﹤0.01% |
3,600
| – | – |
|
1748
Fabrinet
FN
$15.1B
| $206K | ﹤0.01% |
+2,000
| New | +$196K |
|
|
FOCL
1749
EDAP TMS S.A.
FOCL
$157M
| $205K | ﹤0.01% |
32,100
-9,400
| -23% | -$57.5K |
|
1750
Helios Technologies
HLIO
$2.44B
| $205K | ﹤0.01% |
2,500
-100
| -4% | -$8.16K |
|
Similar funds
Steve Schonfeld's Q3 2021 Portfolio in Review
As of Q3 2021, Steve Schonfeld held 2,698 positions worth $9.68B, up 3% from $9.4B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Steve Schonfeld deployed $368M of net new capital in Q3 2021, opening 807 new positions and adding to 606 existing holdings. Its largest new stake was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Amazon, an estimated $110M trimmed.
- Steve Schonfeld's largest Q3 2021 buy was Arthur J. Gallagher & Co: 770,871 shares worth $115M.
- Steve Schonfeld added most to Willis Towers Watson in Q3 2021, an estimated $70.4M increase.
- Steve Schonfeld's biggest Q3 2021 reduction was Amazon, cutting an estimated $110M.
- Steve Schonfeld fully exited Cardinal Health in Q3 2021, selling an estimated $41.2M.
- Steve Schonfeld's ten largest holdings make up 11% of its $9.68B portfolio in Q3 2021.
- Steve Schonfeld opened 807 new positions and closed 588 in Q3 2021.
- Steve Schonfeld's portfolio value rose 3% quarter-over-quarter to $9.68B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.